Bob Huang
Directeur/Bestuurslid bij Travecta Therapeutics Pte Ltd.
Profiel
Bob Huang is currently the Director at Travecta Therapeutics Pte Ltd.
and Investment Director at Seidler Equity Australia.
He holds a doctorate from The University of New South Wales and an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Bob Huang
| Bedrijven | Functie | Begin |
|---|---|---|
| Seidler Equity Australia | Private Equity Investor | 01-01-2017 |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Directeur/Bestuurslid | 27-10-2021 |
Opleiding van Bob Huang
| The University of New South Wales | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Technology Services |
| Seidler Equity Australia | Finance |
